Hasil Filter

13591

Total database: 17430
Struktur (SMILES)
10177 (74.9%)
Target
7625 (56.1%)
Genomik
104 (0.8%)
Referensi
13591 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (13591)

Halaman 261 / 272
Uzansertib DB17571
small molecule | CAS: 2088852-47-3

Uzansertib is under investigation in clinical trial NCT02587598 (Study of INCB053914 in Subjects With Advanced Malignancies).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
V-SARS DB15812
biotech

[COVID-19 convalescent plasma] is currently being acquired from recovered COVID-19 patients and used as prophylaxis for the virus. This therapeutic concept was applied to the development of V-SARS, which heat inactivates the plasma, and packages it into a onc…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
V1003 DB05046
small molecule

V1003 is an intranasal formulation of buprenorphine, an opiate analgesic, for the management of post-operative pain in hospital and home settings. Buprenorphine is a well-known analgesic and the intranasal formulation has the potential to provide a convenient…

Target Protein:
Kappa-type opioid receptorMu-type opioid receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
V116517 DB16060
small molecule | CAS: 1073616-61-1

V116517 is under investigation in clinical trial NCT01688947 (Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)).

Kategori:
AminesPyridines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
V24343 DB05201
small molecule

The anti-obesity drug, V24343, acts by targeting the CB1 receptor in the brain and suppressing a person's appetite.

Target Protein:
Cannabinoid receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
V590 DB16437
biotech

The V590 vaccine was developed on Merck’s recombinant vesicular stomatitis virus (rVSV) platform that was previously used to develop its Ebola Zaire virus vaccine, ERVEBO®[A226818, L30573, L30578]. By teaming up with IAVI, Merk developed a vaccine that does n…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
V591 DB16438
biotech

The V591 vaccine, part of Merck’s COVID-19 vaccine programming, was developed using a modified measles vaccine virus as a vector for COVID-19 antigen delivery[L30593]. Through Merck’s acquisition of Thermis in May 2020, they were able to leverage Thermis’ pla…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VA-MENGOC-BC® DB15800
biotech

VA-MENGOC-BC is a meningococcal B and C vaccine and an outer membrane vesicle (OMV)-based vaccine. The OMVs contain over 100 proteins, and are derived from meningococcal group B and capsular polysaccharide of meningococcal group C. As there already exists a p…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vaborbactam Approved DB12107
small molecule | CAS: 1360457-46-0

Vaborbactam is a ?-lactamase inhibitor based on a cyclic boronic acid pharmacophore.[A32053] It has been used in trials investigating the treatment of bacterial infections in subjects with varying degrees of renal insufficiency. In August 2017, a combination …

Kategori:
AcidsAcids, NoncarboxylicAnti-Infective Agents +6
Target Protein:
Beta-lactamaseBeta-lactamaseCarbapenem-hydrolyzing beta-lactamase KPC +7
Waktu ParuhThe half life of va…
Vol. DistribusiThe steady-state vo…
KlirensThe mean renal clea…
Genetik -
Vactosertib DB15310
small molecule | CAS: 1352608-82-2

Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer).

Kategori:
AminesEnzyme InhibitorsProtein Kinase Inhibitors
Target Protein:
TGF-beta receptor type-1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VAD-044 DB17697
small molecule

VAD-044 is an allosteric AKT inhibitor developed by Vaderis Therapeutics AG. It is being investigated for the treatment of Hereditary Hemorrhagic Telangiectasia.[L46098]

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vadadustat Approved DB12255
small molecule | CAS: 1000025-07-9

One of the most common symptoms of advanced renal disease is anemia, caused primarily by the inability of the kidney to respond to anemic conditions with a corresponding increase in [erythropoietin] (EPO) production.[A244165] The treatment of anemia associate…

Kategori:
Amino AcidsAmino Acids, Peptides, and ProteinsAntianemic Preparations +20
Target Protein:
Egl nine homolog 1Prolyl hydroxylase EGLN2Prolyl hydroxylase EGLN3 +2
Waktu ParuhIn patients with di…
Vol. DistribusiThe apparent volume…
KlirensIn healthy subjects…
Genetik -
biotech | CAS: 1436390-64-5

Vadastuximab Talirine has been used in trials studying the treatment of Acute myeloid leukemia, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, and Acute Promyelocytic Leukemia.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +8
Target Protein:
Myeloid cell surface antigen CD33
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vadimezan DB06235
small molecule | CAS: 117570-53-3

Deskripsi belum tersedia.

Kategori:
Antineoplastic AgentsCytochrome P-450 CYP1A2 SubstratesCytochrome P-450 Substrates +4
Target Protein:
Transcription factor RelBNuclear factor NF-kappa-B p105 subunitNuclear factor NF-kappa-B p100 subunit +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vafidemstat DB16446
small molecule | CAS: 1357362-02-7

Vafidemstat is under investigation in clinical trial NCT03867253 (Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease).

Kategori:
Oxazoles
Target Protein:
Lysine-specific histone demethylase 1AAmine oxidase [flavin-containing] B
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valaciclovir Approved DB00577
small molecule | CAS: 124832-26-4

Valaciclovir (valacyclovir), also known as _Valtrex_, is an antiviral drug that has been used to manage and treat various herpes infections for more than 2 decades. It was initially approved by the FDA in 1995 [FDA label] and marketed by GlaxoSmithKline [L56…

Kategori:
Acyclovir and prodrugAmino AcidsAmino Acids, Branched-Chain +19
Target Protein:
Thymidine kinaseDNA polymerase catalytic subunit
Waktu ParuhThe plasma eliminat…
Vol. DistribusiCerebrospinal fluid…
KlirensRenal clearance of …
Genetik -
Valanafusp alfa DB15336
biotech | CAS: 1815583-32-4

Valanafusp alfa is under investigation in clinical trial NCT03071341 (Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesBlood Proteins +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valbenazine Approved DB11915
small molecule | CAS: 1025504-45-3

Valbenazine is a modified metabolite of [tetrabenazine], and it is currently being approved for the treatment of various movement disorders, particularly tardive dyskinesia and chorea associated with Huntington's disease.[L47885,A261135] Tardive dyskinesia ha…

Kategori:
Amino AcidsAmino Acids, Branched-ChainAmino Acids, Peptides, and Proteins +11
Target Protein:
Synaptic vesicular amine transporter
Waktu ParuhBoth Valbenazine an…
Vol. DistribusiThe mean steady-sta…
KlirensValbenazine has a m…
Genetik -
Valemetostat DB18314
small molecule | CAS: 1809336-39-7

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valerian Approved DB13196
biotech | CAS: 8057-49-6

Valerian is extracted from a herb that is a perennial flowering plant. Valerian root is reported to have sedative and anxiolytic effects however its mechanism of action is not completely understood. Valerian has been used in the treatment of conditions includ…

Kategori:
AngiospermsBiological ProductsCentral Nervous System Depressants +15
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valethamate DB13497
small molecule | CAS: 16376-74-2

Deskripsi belum tersedia.

Kategori:
Alimentary Tract and MetabolismAminesAmmonium Compounds +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 238401-16-6

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 1034190-08-3

Valiltramiprosate is under investigation in clinical trial NCT06304883 (Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects).

Kategori:
AlkanesAlkanesulfonic AcidsAmino Acids +7
Target Protein:
Amyloid-beta precursor protein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valine Approved DB00161
small molecule | CAS: 72-18-4

Valine is a branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.

Kategori:
Amino AcidsAmino Acids, Branched-ChainAmino Acids, Essential +4
Target Protein:
Propionyl-CoA carboxylase beta chain, mitochondrialBranched-chain-amino-acid aminotransferase, cytosolicValine--tRNA ligase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 897937-73-4

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valinomycin DB14057
small molecule | CAS: 2001-95-8

A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered …

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Bacterial AgentsAnti-Infective Agents +9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valnoctamide DB13099
small molecule | CAS: 4171-13-5

Valnoctamide has been used in trials studying the treatment of Mania and Schizoaffective Disorder, Manic Type.

Kategori:
Central Nervous System DepressantsHypnotics and SedativesNervous System +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valoctocogene roxaparvovec Approved DB15561
biotech | CAS: 1819334-78-5

Valoctocogene roxaparvovec is an adeno-associated virus serotype 5 (AAV5) based gene therapy vector that expresses the B-domain deleted SQ form of human coagulation factor VIII (hFVIII-SQ).[L43282] The expression of hFVIII-SQ is driven by a liver-specific pro…

Kategori:
Adeno-associated Viral Vector TherapiesAmino Acids, Peptides, and ProteinsBiological Factors +9
Target Protein:
Coagulation factor VIII (F8)
Waktu Paruh-
Vol. Distribusi-
KlirensThe maximum time to…
Genetik -
Valomaciclovir DB06575
small molecule | CAS: 195157-34-7

Deskripsi belum tersedia.

Kategori:
Antiviral AgentsHerpes ZosterHeterocyclic Compounds, Fused-Ring +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 195156-77-5

Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster).

Kategori:
Antiviral AgentsHerpes ZosterHeterocyclic Compounds, Fused-Ring +4
Target Protein:
DNA polymerase catalytic subunit
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valopicitabine DB13920
small molecule | CAS: 640281-90-9

The 3-O-valine ester prodrug of the nucleoside analog 2'-C-methylcytidine with anti-hepatitis C virus (HCV) activity. Upon administration, valopicitabine is converted into 2'-C-methylcytidine; upon phosphorylation into its 5-triphosphate form, this metabolite…

Kategori:
Nucleic Acids, Nucleotides, and NucleosidesNucleosidesPyrimidines
Target Protein:
Genome polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valproate bismuth Approved DB13910
small molecule | CAS: 60364-28-5

Valproate bismuth is available in Canada in the over-the-counter medication Neo-Laryngobis.

Kategori:
Bismuth containing drugsEENT Drugs, MiscellaneousNeurotoxic agents +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valproic acid Approved DB00313
small molecule | CAS: 99-66-1

Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton.[A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a…

Kategori:
Acids, AcyclicAnti-epileptic AgentAnticonvulsants +68
Target Protein:
4-aminobutyrate aminotransferase, mitochondrialGlycogen synthase kinase-3 alphaHistone deacetylase 9 +13
Gen Terkait:
POLG POLG
Waktu Paruh13-19 hours.[label]…
Vol. Distribusi11 L/1.73m<sup>2</s…
Klirens0.56 L/hr/m<sup>2</…
Genetik 2 Varian
Valrocemide DB06657
small molecule | CAS: 92262-58-3

Deskripsi belum tersedia.

Kategori:
Amino AcidsAmino Acids, Peptides, and Proteins
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valrubicin Approved DB00385
small molecule | CAS: 56124-62-0

Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is a chemotherapy drug commonly marketed under the trade name VALSTAR. It is a semisynthetic analog of the [doxorubicin], which is an anthracycline drug. Used in the treatment of the bladder cancer, valrub…

Kategori:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related Substances +9
Target Protein:
DNADNA topoisomerase 2-betaDNA topoisomerase 2-alpha
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valsartan Approved DB00177
small molecule | CAS: 137862-53-4

Valsartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [olmesartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiote…

Kategori:
Agents Acting on the Renin-Angiotensin SystemAgents causing angioedemaAgents causing hyperkalemia +22
Target Protein:
Type-1 angiotensin II receptor
Waktu ParuhAfter intravenous (…
Vol. DistribusiThe steady-state vo…
KlirensFollowing intraveno…
Genetik -
Valtorcitabine DB06187
small molecule | CAS: 380886-95-3

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vamifeport DB17692
small molecule | CAS: 2095668-10-1

Vamifeport is being investigated for the treatment of beta-thalassemia.

Kategori:
Heterocyclic Compounds, Fused-Ring
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vamikibart DB18896
biotech | CAS: 2744320-12-3

Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vamorolone Approved DB15114
small molecule | CAS: 13209-41-1

Vamorolone is a novel and fully synthetic glucocorticoid developed by Santhera Pharmaceuticals. It is used to manage inflammation and immune dysregulation in patients with Duchenne muscular dystrophy (DMD), a neuromuscular disorder characterized by the insidi…

Kategori:
Adrenal Cortex HormonesAnti-Inflammatory AgentsCorticosteroids +20
Target Protein:
Glucocorticoid receptorMineralocorticoid receptor
Waktu ParuhThe terminal elimin…
Vol. DistribusiBased on population…
KlirensBased on population…
Genetik -
Vamotinib DB15396
small molecule | CAS: 1416241-23-0

Vamotinib (PF-114) is under investigation in clinical trial NCT02885766 (Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanadium Approved DB13971
small molecule | CAS: 7440-62-2

Deskripsi belum tersedia.

Kategori:
Diet, Food, and NutritionElementsFood +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vandetanib Approved DB05294
small molecule | CAS: 443913-73-3

Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types. On April 6 2011, vandetanib was approved by the FDA to treat nonresectable, locally advanced…

Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 Inhibitors +15
Target Protein:
Vascular endothelial growth factor receptor 2Proto-oncogene tyrosine-protein kinase receptor RetEpidermal growth factor receptor +3
Waktu ParuhMedian half life of…
Vol. DistribusiVd of about 7450 L.
Klirens-
Genetik -
biotech | CAS: 2382896-00-4

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanillic acid DB02130
small molecule | CAS: 121-34-6

A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13).

Kategori:
Acids, CarbocyclicBenzene DerivativesBenzoates +5
Target Protein:
Chorismate pyruvate-lyase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vaniprevir DB11929
small molecule | CAS: 923590-37-8

Vaniprevir has been used in trials studying the treatment and diagnostic of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, Chronic Hepatitis C Infection, and Chronic Genotype 1 Hepatitis C Virus Infection.

Kategori:
AmidesAmino AcidsAmino Acids, Branched-Chain +9
Target Protein:
Gag-Pol polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanoxerine DB03701
small molecule | CAS: 67469-69-6

Vanoxerine is a highly selective dopamine transporter antagonist. It was synthesized in the late 1970s and developed as a potential treatment for depression.[A19824] Vanoxerine was later evaluated as a potential treatment for cocaine addiction due to its abil…

Kategori:
Antiarrhythmic agentsCytochrome P-450 CYP3A SubstratesCytochrome P-450 CYP3A4 Substrates +6
Target Protein:
Sodium-dependent dopamine transporterHERG human cardiac K+ channel
Waktu ParuhThe mean eliminatio…
Vol. DistribusiVanoxerine is capab…
KlirensAt 25, 75 and 125 m…
Genetik -
Vantictumab DB12956
biotech | CAS: 1345009-45-1

Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanucizumab DB12317
biotech | CAS: 1448221-05-3

Vanucizumab has been used in trials studying the treatment of ColoRectal Cancer and Advanced/Metastatic Solid Tumors.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +7
Target Protein:
Angiopoietin-2Vascular endothelial growth factor A, long form
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 13001–13050 dari 13591
Sebelumnya Halaman 261 / 272 Berikutnya